Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 70 of 70 entries
View as:

Comparative Study of Three NNRTI-Sparing HAART Regimens

Phase: N/A Priority: Normal
NCT ID: NCT00811954 Org: User:
Start: 05/31/09 End: 06/30/13 Due: 06/30/14

High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART

Phase: N/A Priority: Normal
NCT ID: NCT01403051 Org: User:
Start: 09/30/11 End: 02/28/13 Due: 02/28/14

Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection

Phase: N/A Priority: Normal
NCT ID: NCT03512210 Org: User:
Start: 10/22/18 End: 02/28/21 Due: 02/28/22

Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS

Phase: N/A Priority: Normal
NCT ID: NCT01435018 Org: User:
Start: 10/01/13 End: 08/29/19 Due: 08/29/20

Rifaximin as a Modulator of Microbial Translocation and Immune Activation

Phase: N/A Priority: Normal
NCT ID: NCT01466595 Org: User:
Start: 09/30/11 End: 11/30/12 Due: 11/30/13

Modulation of Immune Activation by Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT02155985 Org: User:
Start: 08/31/14 End: 07/31/15 Due: 07/31/16

HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00442962 Org: User:
Start: 05/31/07 End: 12/31/10 Due: 12/31/11

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00090779 Org: User:
Start: 01/31/05 End: 05/31/11 Due: 05/31/12

Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients

Phase: N/A Priority: Normal
NCT ID: NCT02582684 Org: User:
Start: 12/08/15 End: 09/26/17 Due: 09/26/18

Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women

Phase: N/A Priority: Normal
NCT ID: NCT01296152 Org: User:
Start: 05/31/11 End: 10/31/12 Due: 10/31/13

Consent for Use of Stored Patient Specimens for Future Testing

Phase: N/A Priority: Normal
NCT ID: NCT00031408 Org: User:
Start: 02/13/02 End: 12/31/27 Due: 12/31/28

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Phase: N/A Priority: Normal
NCT ID: NCT02412436 Org: User:
Start: 11/03/15 End: 06/15/17 Due: 06/15/18

Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT02128217 Org: User:
Start: 05/30/14 End: 05/09/17 Due: 05/09/18

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT00108862 Org: User:
Start: 08/31/06 End: 07/31/10 Due: 07/31/11

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Phase: N/A Priority: Normal
NCT ID: NCT00709111 Org: User:
Start: 01/31/09 End: 04/30/10 Due: 04/30/11

PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)

Phase: N/A Priority: Normal
NCT ID: NCT03070223 Org: User:
Start: 03/14/17 End: 08/21/23 Due: 08/21/24

Telephone Support to Improve Adherence to Anti-HIV Medications

Phase: N/A Priority: Normal
NCT ID: NCT00988442 Org: User:
Start: 10/31/10 End: 02/28/13 Due: 02/28/14

Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD

Phase: N/A Priority: Normal
NCT ID: NCT04050449 Org: User:
Start: 10/28/19 End: 03/31/23 Due: 03/31/24

Early ART to Limit Infection and Establishment of Reservoir

Phase: N/A Priority: Normal
NCT ID: NCT02859558 Org: User:
Start: 01/31/17 End: 04/30/25 Due: 04/30/26

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT00001137 Org: User:
Start: 01/31/00 End: 11/30/13 Due: 11/30/14